Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Immunological Reviews|September 9, 2024
Immune checkpoint inhibitors in infectious diseaseHannah A D King, Sharon R LewinVaccines|April 3, 2021
Immunogenicity of HIV-1-Based Virus-Like Particles with Increased Incorporation and Stability of Membrane-Bound EnvChristopher A Gonelli, Hannah A D King, Charlene Mackenzie, et al.Current Opinion in HIV and AIDS|November 21, 2025
Immunotherapy and impact on tissue reservoirsHannah A D King, Thomas A Angelovich, Michael A Moso, et al.Antiviral Research|June 21, 2025
Host-directed approaches in the pursuit of a cure for HIVRory A Shepherd, Kiho Tanaka, Hannah A D King, et al.Plos One|August 21, 2019
Conjugation of an scFab domain to the oligomeric HIV envelope protein for use in immune targetingHannah A D King, Christopher A Gonelli, Kirsteen M Tullett, et al.The Journal of Biological Chemistry|March 3, 2018
Distinct functions for the membrane-proximal ectodomain region (MPER) of HIV-1 gp41 in cell-free and cell-cell viral transmission and cell-cell fusionVani G S Narasimhulu, Anna K Bellamy-McIntyre, Annamarie E Laumaea, et al.Journal of Virology|February 25, 2026
Methaneseleninic acid, a circadian-modulating agent, reactivates latent HIV-1 infection without cellular activation or proliferationJared Stern, Rory A Shepherd, Youry Kim, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2023
Immune Activation Profiles Elicited by Distinct, Repeated TLR Agonist Infusions in Rhesus MacaquesHannah A D King, Supriya Pokkali, Dohoon Kim, et al.Nature|February 5, 2025
Antibody prophylaxis may mask subclinical SIV infections in macaquesChristopher A Gonelli, Hannah A D King, SungYoul Ko, et al.Science (New York, N.Y.)|September 7, 2019
Blocking α<sub>4</sub>β<sub>7</sub> integrin binding to SIV does not improve virologic controlNami Iwamoto, Rosemarie D Mason, Kaimei Song, et al.Pageof 3